3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
13
Neoplasm Metastasis
9
Stomach Neoplasms
5
Endometrial Neoplasms
4
Pancreatic Neoplasms
3
Ovarian Neoplasms
3
Adenocarcinoma
3
Salivary Gland Neoplasms
2
Prostatic Neoplasms
2
Esophageal Neoplasms
2
Colorectal Neoplasms
2
Brain Neoplasms
2
Vulvar Neoplasms
1
Vaginal Neoplasms
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Urethral Neoplasms
1
Unresectable Locally Recurrent Breast Cancer
1
Triple Negative Breast Neoplasms
1
Thyroid Neoplasms
1
Testicular Neoplasms
1
Small Cell Lung Carcinoma
1
Sarcoma
1
Parkinson Disease 4, Autosomal Dominant Lewy Body
1
Osteosarcoma
1
Neoplasms
1
Neoplasm, Residual
1
Mouth Neoplasms
1
Melanoma
1
Interventions
Cyclophosphamide
11
fludarabine
8
Dexamethasone
7
pomalidomide
6
pembrolizumab
6
Rituximab
5
obinutuzumab
4
glofitamab
4
daratumumab
4
Immunotherapy, Adoptive
4
Gemcitabine
4
Bortezomib
4
venetoclax
3
selinexor
3
fludarabine phosphate
3
cemiplimab
3
Temozolomide
3
Nivolumab
3
Melphalan
3
Injections
3
Etoposide
3
zanubrutinib
2
tocilizumab
2
pirtobrutinib
2
blinatumomab
2
abemaciclib
2
Sirolimus
2
Oxaliplatin
2
Mesna
2
Lisaftoclax
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Recurrence
×
trastuzumab deruxtecan
×
30 days
×
Clear all
No trials found.